Eficácia da midostaurina na mastocitose sistêmica um relato de caso / Efficacy of midostaurin in systemic mastocytosis: a case report
Arq Asma Alerg Imunol
; 8(1): 80-84, jan.mar.2024. ilus
Article
in En, Pt
| LILACS
| ID: biblio-1562901
Responsible library:
BR2717.9
RESUMO
Paciente do sexo feminino, com 63 anos de idade, portadora de mastocitose sistêmica há cerca de 20 anos, sendo agressiva há 10 anos. Crises quase diárias com manifestações do trato gastrointestinal e vasomotoras. Após diversas tentativas de tratamento, iniciou uso de midostaurina, um inibidor multiquinase. Depois de 6 meses de uso, observou-se bom controle dos sintomas, diminuição em quase 50% da triptase sérica e desaparecimento completo das lesões cutâneas.
ABSTRACT
A 63-year-old female presented with an approximately 20-year history of systemic mastocytosis, which had become aggressive over the past 10 years. She experienced almost daily episodes of gastrointestinal and vasomotor manifestations. After multiple treatment attempts, she was started on midostaurin, a multikinase inhibitor. At 6 months of therapy, satisfactory control of symptoms was achieved, with a nearly 50% reduction in serum tryptase and complete resolution of cutaneous lesions.
Key words
Full text:
1
Collection:
01-internacional
Database:
LILACS
Main subject:
Cyclin-Dependent Kinase Inhibitor Proteins
Limits:
Female
/
Humans
Language:
En
/
Pt
Journal:
Arq Asma Alerg Imunol
Year:
2024
Document type:
Article
Affiliation country:
Brazil